|
Home : Environmental Toxins : Mesothelioma : Newsfeeds : Lilly profit rises as sales eclipse forecasts Lilly profit rises as sales eclipse forecasts
CNBC - Sales of Alimta, used to treat tumors caused by exposure to asbestos, soared 42 percent to $244 million, helped by its other approved use against lung cancer. Sales of Gemzar, an older lung cancer drug, rose 15 percent to $426 million. (Reporting ...
Find a Mesothelioma Lawyer Now
This form is secure and encrypted. More information about secure forms and your privacy here.
|




